<DOC>
	<DOCNO>NCT02220972</DOCNO>
	<brief_summary>This multi-center , randomize , double-blind , placebo-controlled , crossover study evaluate effect 2007/Fycompa ( perampanel ) sleep , subject well control partial onset seizure ( antiepileptic drug [ AED ] monotherapy ) experience sleep onset insomnia .</brief_summary>
	<brief_title>To Evaluate Effect Perampanel Objective Subjective Sleep Subjects With Insomnia Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<criteria>1 . Have diagnosis epilepsy partial onset seizure without secondary generalization , accord ILAE Classification Epileptic Seizures ( 1981 ) . Diagnosis establish clinical history , chart confirmation previous EEG consistent localizationrelated epilepsy ; normal interictal EEGs allow provide subject meet diagnosis criterion ( ie , clinical history ) . 2 . Subjects well control ( define less 1 seizure every 28 day ) period least 3 month current AED monotherapy ( define single AED take least 28 day Screening ) , history AED polytherapy . 3 . Male female subject , least 18 year 50 year age time inform consent 4 . Body Mass Index 18 30 kg/m2 5 . Meets Diagnostic Statistical Manual5 criterion Insomnia Disorder : 1 . Complains dissatisfaction nighttime sleep form difficulty get sleep difficulty stay asleep 2 . Frequency complaint least 3 time per week 3 . Duration complaint least 3 month 4 . Associated complaint daytime impairment 6 . Confirmed problem sleep onset insomnia evidence response `` Time Fall Asleep '' question PSQI Screening least 45 minute 7 . Confirmed problem sleep onset insomnia evidence habitual median sSOL least 45 minute obtain sleep diary response last consecutive 7 day Screening/Baseline Period 8 . Confirmed problem sleep onset insomnia evidence LPS least 20 minute baseline PSG 9 . Provide write informed consent , sign subject enter study undergo study procedure 10 . Willing able comply aspect protocol 11 . Females must lactate pregnant Screening Baseline ( document negative betahuman chorionic gonadotropin [ BhCG ] human chorionic gonadotropin [ hCG ] test minimum sensitivity 25 IU/L equivalent unit BhCG [ hCG ] ) . A separate baseline assessment require negative screening pregnancy test obtain 72 hour first dose study drug . 12 . All female consider childbearing potential unless postmenopausal ( amenorrheic least 12 consecutive month , appropriate age group , without know suspected cause ) sterilize surgically ( ie , bilateral tubal ligation , total hysterectomy , bilateral oophorectomy , surgery least 1 month dose ) . 13 . Females childbearing potential must participate conception process ( ie , active attempt become pregnant impregnate , vitro fertilization ) must unprotected sexual intercourse within 30 day study entry must agree use highly effective method contraception ( eg , total abstinence , intrauterine device , doublebarrier method [ condom plus diaphragm spermicide ] , contraceptive implant , oral contraceptive , vasectomized partner confirm azoospermia ) , least 4 week dosing , throughout entire study period 4 week study drug discontinuation . If currently abstinent , subject must agree use doublebarrier method describe becomes sexually active study period 4 week study drug discontinuation . Females use hormonal contraceptive must stable dose hormonal contraceptive product least 4 week dose must continue use contraceptive study 4 week study drug discontinuation . Exclusion criteria 1 . Hypersensitivity component Fycompa 2 . Subjects sleep problem ( except sleep onset mixed sleep onset sleep maintenance insomnia ) base history , standard sleep questionnaire , PSG Screening . 3 . Subjects diagnosis sleeprelated breathe disorder , apneahypopnea index 15 , periodic limb movement disorder 15 , restless legs syndrome , nightmare disorder , sleep terror disorder , sleepwalk disorder , REM behavior disorder , narcolepsy , circadian rhythm sleep disorder . 4 . Subjects current evidence unstable psychotic disorder , major depressive disorder , bipolar disorder , generalize anxiety disorder base psychiatric interview Screening , subject diagnose psychotic disorder major depressive disorder within 2 year Screening base clinical history 5 . Subjects strong cytochrome P450 ( CYP ) 3A inducer AEDs ( eg , rifampin , St. John 's Wort ) 6 . Subjects EIAEDs : carbamazepine , oxcarbazepine , phenytoin eslicarbazepine ( presumed EIAED ) 7 . Using prescription counter medication purpose treat sleep disturbance , include sedate antihistamine , within 14 day dose 8 . Transmeridian travel across 3 time zone 2 week Screening , plan travel across 3 time zone study 9 . Excessive caffeine use ( defined 4 cup coffee day , equivalent ) 10 . Shift worker , define subject typically start work hour 16:00 ( 4 pm ) 4:00 ( 4 ) 11 . Any history medical condition concomitant medical condition opinion investigator ( ) would compromise subject 's ability safely complete study , include significantly abnormal laboratory result physical mental condition prevents compliance protocol 12 . Use illegal recreational drug recent history ( within 2 year Screening Visit ) alcohol drug/solvent dependency abuse positive screen drug abuse use standard Urine Drug Screen Screening 13 . A clinically significant electrocardiogram ( ECG ) abnormality , include prolonged QT interval/corrected QT interval define 450 msec base ECG Screening 14 . Currently enrol another clinical study participate clinical study investigational drug , biologic , device within 1 month Screening ( Visit 1 ) , within approximately 5 halflives previous investigational compound , whichever longer 15 . Previous use perampanel participate previous perampanel study 16 . Any suicidal ideation intent without plan Screening Baseline within 6 month Screening ( ie , answer 'Yes ' question Suicidal Ideation section electronic version Columbia Suicide Severity Rating Scale [ eCSSRS ] ) 17 . Suicide attempt ( ) within approximately last 2 year suicidal ideation within last 6 month Screening visit ( use Suicidal Behavior Section eCSSRS ) 18 . Evidence significant active hepatic disease . Stable elevation liver enzyme , alanine aminotransferase aspartate aminotransferase due concomitant medication ( ) allow less 3 time upper limit normal 19 . Evidence clinically significant disease ( eg , cardiac , respiratory , gastrointestinal , renal disease ) opinion Investigator ( ) could affect subject 's safety interfere study assessment 20 . Presence progressive central nervous system ( CNS ) disease , include degenerative CNS disease progressive tumor 21 . Presence implant vagal nerve stimulator 22 . Have multiple drug allergy severe drug reaction AED , include dermatological ( eg , StevensJohnson syndrome ) , hematological , organ toxicity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Partial Onset Seizures</keyword>
	<keyword>Insomnia</keyword>
</DOC>